Impact of ETI Therapy on CFTR Function in N1303K Variant Patients
發布者：Unknown
·發布於：2025-12-13
Discussion regarding the effectiveness of the triple combination therapy Elexacaftor+Tezacaftor+Ivacaftor (ETI) in restoring CFTR function specifically for Cystic Fibrosis patients with the N1303K variant.
載入中...